2020—2023年某院门诊患者他汀类药物使用情况分析

Analysis of Statins Use in Outpatients of a Hospital from 2020 to 2023

目的:回顾分析天津市宝坻区人民医院2020—2023年门诊使用他汀类药物患者的信息,评价分析该药物的使用情况,为临床合理用药给予理论指导。方法:使用PASS系统统计使用他汀类药物患者的基本信息,包括年龄、性别;采用世界卫生组织推荐的限定日剂量(DDD)分析方法,计算每种他汀类药物的用药频度(DDDs),日均费用(DDC)。结果:用药频度及金额排序靠前的是阿托伐他汀、瑞舒伐他汀两种药物,且同步相关性较好,其中阿托伐他汀的用药金额、DDDs每年都呈上升趋势;从数据显示,阿托伐他汀尤其在2022年和2023年呈稳步上升趋势,分别较上一年增长49%和55%,社会效益和经济效益良好。结论:我院应该进一步加强他汀类药物的科学管理,使符合安全、合理、有效、经济的用药原则。

Objective:To retrospectively analyze the information of outpatients using statins in Tianjin Baodi District People’s Hospital from 2020 to 2023,evaluate and analyze the use of statins,and provide theoretical guidance for clinical rational drug use.Methods:The PASS system was used to count the basic information of patients using statins,including age and gender;the defined daily dose(DDD)analysis method recommended by the World Health Organization was used to calculate the defined daily doses(DDDs)and defined daily dose cost(DDC)of each statin.Results:The top ranked drugs in terms of medication frequency and amount were atorvastatin and rosuvastatin,with good synchronous correlation.Among them,atorvastatin’s medication amount and DDDs were on the rise every year.The data showed that atorvastatin with a steady upward trend,especially in 2022 and 2023,with growth rates of 49%and 55%respectively compared to the previous year,indicating good social and economic benefits.Conclusion:Our hospital should further strengthen the scientific management of statin drugs to comply with the principles of safe,reasonable,effective,and economical.